Electric And Magnetic Fields |
Cell Phones; Electromagnetic Fields; EMF |
Clinical Trial: High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation
This study is not yet open for patient recruitment.
Verified by Alberta Cancer Board August 2005
Purpose
| Condition | Intervention |
|---|---|
| Prostatic Neoplasm | Procedure: Magnetic Resonance Spectroscopy Imaging |
MedlinePlus related topics: Prostate Cancer
Study Type: Interventional
Study Design: Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Official Title: High Field (3 Tesla) Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Permanent Iodine 125 Brachytherapy Implantation
Secondary Outcomes: safety/toxicity
Expected Total Enrollment: 10
Study start: October 2005
Eligibility
Inclusion Criteria:
- Suitable candidate for prostate brachytherapy to treat prostate cancer
- Patient signs a study consent form
Exclusion Criteria:
- Have received other radiotherapy for prostate cancer or hormone treatments
- Has contraindication to MRSI scanning
- Does not sign study consent form
Location and Contact Information
Canada, Alberta
Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada
Don Yee, MD, Principal Investigator
Don Yee, MD, Principal Investigator, Alberta Cancer Board
More Information
Last Updated: August 19, 2005
Record first received: August 3, 2005
ClinicalTrials.gov Identifier: NCT00126854
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2005-08-23
Resources
- Electric And Magnetic Fields (National Women's Health Information Center)
- EMF (Electric and Magnetic Fields): Questions and Answers (National Institute of Environmental Health Sciences)

Not Signed In -

